Neurosurgery (CNSS) Day PM: Schwannoma / Neurofibroma

Thursday, May 23, 2024

1:45 PM – 4:15 PM EST

Location:MM: NWT

CE: 2.5

Audience:

Adult Neurologist, Child Neurologist, Neurosurgeon, Neuroradiologist, Neurophysiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Discussion group/peer exchange/user groups, Lecture/plenary method, Question and answer sessions

CanMEDs Roles:

Medical Expert, Scholar, Communicator, Collaborator, Leader, Health Advocate, Professional

Chair(s)

CB

Carolina Barnett-Tapia
SS

Suganth Suppiah

Speaker(s)

RM

Rajiv Midha

Co-Chair(s)

GZ

Gelareh Zadeh
FP

Farhad Pirouzmand

Speaker(s)

MT

Marcos Tatagiba
DT

Derek Tsang
RA

Ryojo Akagami
WC

William Couldwell
ML

Michael Link

This comprehensive course, offers an in-depth exploration of Schwannoma and Neurofibroma, focusing on the latest surgical, molecular, and therapeutic advances in both benign and malignant peripheral nerve sheath tumors. Engage with experts across multiple disciplines, including surgery, oncology, and genetics, for a multidisciplinary perspective on cutting-edge treatment strategies and patient care.

For more details visit UofT Division of Neurosurgery: Celebrating 100 Years and Beyond (uoftnsx100years.ca)

Learning Objectives:

Understand the surgical decision-making process and techniques for both benign and malignant peripheral nerve sheath tumors, including the role of Gamma Knife Radiosurgery and advances in surgical approaches to Vestibular Schwannomas.
Explore the molecular landscape of malignant peripheral nerve sheath tumors (MPNST) and the indications for MEK inhibitors in Neurofibromatosis (NF), emphasizing the integration of molecular diagnostics and targeted therapies in patient management.
Evaluate the benefits of a multidisciplinary approach to Neurofibromatosis, including the development of specialized programs and virtual tumor boards, to enhance collaborative patient care and outcomes.

Presentations:

1:45 PM – 1:50 PM EST

Opening Remarks
Speaker: Suganth Suppiah
1:50 PM – 2:05 PM EST

Approach to Surgery for Benign Peripheral Nerve Sheath Tumors
Speaker: Rajiv Midha
2:05 PM – 2:20 PM EST

Advances in Molecular Landscape of MPNST
Speaker: Suganth Suppiah
2:20 PM – 2:35 PM EST

Indications for MEK inhibitors in NF
Speaker: Carolina Barnett-Tapia
2:35 PM – 2:50 PM EST

Discussion - All Speakers
Speaker: Rajiv Midha
Speaker: Suganth Suppiah
Speaker: Carolina Barnett-Tapia
Speaker: Marcos Tatagiba
Speaker: Derek S. Tsang
Speaker: Ryojo Akagami
Speaker: William Couldwell
Speaker: Michael Link
2:50 PM – 3:05 PM EST

Management of Acoustic Neuromas
Speaker: Marcos Tatagiba
3:05 PM – 3:20 PM EST

Radiosurgery for Vestibular Schwannomas
Speaker: Derek S. Tsang
3:20 PM – 3:30 PM EST

BREAK
3:30 PM – 3:45 PM EST

Advances in Surgical Approaches to Vestibular Schwannomas
Speaker: Ryojo Akagami
3:45 PM – 4:00 PM EST

Hearing Preservation for Acoustic Neuromas
Speaker: William Couldwell
4:00 PM – 4:15 PM EST

Auditory Brainstem Implants
Speaker: Michael Link